University of Missouri-Columbia School of Health Professions Link to MU Homepage link to MU Homepage School of Health Professions
search  
Virtual Health Care Team
Case StudiesAbout VHCTContinuing EducationHealth ReferencesContact UsHome

Authors:

Archana Goel, MD

Cathy M. Ashbaugh, APRN

University of Missouri Health Care, Columbia, MO

Acknowledgement:

This VHCT case was sponsored by friends and benefactors of the Missouri Kidney Program.

Managing Medication Adverse Effects Post Kidney Transplant

Archana Goel, MD
Cathy M. Ashbaugh, APRN

Introduction

Joan is a 61-year-old white female with end stage renal disease secondary to polycystic kidney disease. Her first kidney transplant was in 1985, which was cadaveric renal transplant (CRT). She developed chronic allograft nephropathy and lost her transplant after nearly 20 years and was restarted on hemodialysis in 2003. She received her second kidney transplant on 4/26/05, which was also a CRT. It was a 0 antigen match. She received immunosuppression prior to and after the transplant as per protocol.

Objectives

  • A large part of post transplant care involves balancing the the use of immunosuppressive medications and preventing and treating complications of immunosuppressive therapy.
  • Drug-related problems can result in hospitalization, morbidity and mortality.
  • To prevent adverse drug interaction an alternative therapy is considered when possible, or the dose or schedule of the drugs should be adjusted to reduce the occurrence of an adverse effect.
  • Careful monitoring to prevent and detect adverse effects is an essential part of patient care.

Published by the Virtual Health Care Team ®
School of Health Professions
University of Missouri-Columbia
Questions? Comments? Contact Us
Copyright © 2006-2012 — Curators of the University of Missouri
DMCA and other copyright information.
An equal opportunity/ADA institution.
All rights reserved. Disclaimer and Terms of Use
Last Update: Dec 3 2012